-
1
-
-
0030707941
-
Hepatitis B virus infection
-
W.M. Lee Hepatitis B virus infection N Engl J Med 337 1997 1733 1745
-
(1997)
N Engl J Med
, vol.337
, pp. 1733-1745
-
-
Lee, W.M.1
-
2
-
-
0027422748
-
From hepatitis to hepatoma: Lessons from type B viral hepatitis
-
D.S. Chen From hepatitis to hepatoma: lessons from type B viral hepatitis Science 262 1993 369 370
-
(1993)
Science
, vol.262
, pp. 369-370
-
-
Chen, D.S.1
-
3
-
-
59149086601
-
Natural history of chronic hepatitis B virus infection and long-term outcome under treatment
-
Y.F. Liaw Natural history of chronic hepatitis B virus infection and long-term outcome under treatment Liver Int 29 2009 100 107
-
(2009)
Liver Int
, vol.29
, pp. 100-107
-
-
Liaw, Y.F.1
-
4
-
-
0033214863
-
Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection
-
C.M. Lee, S.N. Lu, C.S. Changchien, C.T. Yeh, T.T. Hsu, and J.H. Tang et al. Age, gender, and local geographic variations of viral etiology of hepatocellular carcinoma in a hyperendemic area for hepatitis B virus infection Cancer 86 1999 1143 1150
-
(1999)
Cancer
, vol.86
, pp. 1143-1150
-
-
Lee, C.M.1
Lu, S.N.2
Changchien, C.S.3
Yeh, C.T.4
Hsu, T.T.5
Tang, J.H.6
-
5
-
-
0033797827
-
Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea
-
B.C. Song, D.J. Suh, H.C. Lee, Y.H. Chung, and Y.S. Lee Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea Hepatology 32 2000 803 806
-
(2000)
Hepatology
, vol.32
, pp. 803-806
-
-
Song, B.C.1
Suh, D.J.2
Lee, H.C.3
Chung, Y.H.4
Lee, Y.S.5
-
6
-
-
0036844794
-
Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation
-
C.M. Lee, G.Y. Ong, S.N. Lu, J.H. Wang, C.A. Liao, and H.D. Tung et al. Durability of lamivudine-induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation J Hepatol 37 2002 669 674
-
(2002)
J Hepatol
, vol.37
, pp. 669-674
-
-
Lee, C.M.1
Ong, G.Y.2
Lu, S.N.3
Wang, J.H.4
Liao, C.A.5
Tung, H.D.6
-
7
-
-
84984538817
-
Chronic hepatitis B: Whom to treat and for how long? Proposition, challenges, and future directions
-
S.H. Ahn, H.L. Chan, P.J. Chen, J. Cheng, M.K. Goenka, and J. Hou et al. Chronic hepatitis B: whom to treat and for how long? Proposition, challenges, and future directions Hepatol Int 4 2010 386 395
-
(2010)
Hepatol Int
, vol.4
, pp. 386-395
-
-
Ahn, S.H.1
Chan, H.L.2
Chen, P.J.3
Cheng, J.4
Goenka, M.K.5
Hou, J.6
-
8
-
-
0037371186
-
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: Relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase
-
A.B. van Nunen, B.E. Hansen, D.J. Suh, H.F. Löhr, L. Chemello, and H. Fontaine et al. Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase Gut 52 2003 420 424
-
(2003)
Gut
, vol.52
, pp. 420-424
-
-
Van Nunen, A.B.1
Hansen, B.E.2
Suh, D.J.3
Löhr, H.F.4
Chemello, L.5
Fontaine, H.6
-
9
-
-
51049107683
-
Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update
-
Y.F. Liaw, N.W. Leung, J.H. Kao, R. Guan, D.I. Tai, and K.Y. Ng et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update Hepatol Int 2 2008 263 283
-
(2008)
Hepatol Int
, vol.2
, pp. 263-283
-
-
Liaw, Y.F.1
Leung, N.W.2
Kao, J.H.3
Guan, R.4
Tai, D.I.5
Ng, K.Y.6
-
10
-
-
66049153294
-
Withdrawal of lamivudine in HBeAg-positive chronic hepatitis B patients after achieving effective maintained virological suppression
-
C.T. Yeh, C.W. Hsu, Y.C. Chen, and Y.F. Liaw Withdrawal of lamivudine in HBeAg-positive chronic hepatitis B patients after achieving effective maintained virological suppression J Clin Virol 45 2009 114 118
-
(2009)
J Clin Virol
, vol.45
, pp. 114-118
-
-
Yeh, C.T.1
Hsu, C.W.2
Chen, Y.C.3
Liaw, Y.F.4
-
11
-
-
68349128691
-
The duration of lamivudine therapy for chronic hepatitis B: Cessation vs. Continuation of treatment after HBeAg seroconversion
-
J. Fung, C.L. Lai, Y. Tanaka, M. Mizokami, J. Yuen, and D.K. Wong et al. The duration of lamivudine therapy for chronic hepatitis B: cessation vs. continuation of treatment after HBeAg seroconversion Am J Gastroenterol 104 2009 1940 1946
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 1940-1946
-
-
Fung, J.1
Lai, C.L.2
Tanaka, Y.3
Mizokami, M.4
Yuen, J.5
Wong, D.K.6
-
12
-
-
8444233579
-
Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers
-
C.H. Chen, C.M. Lee, J.H. Wang, H.D. Tung, C.H. Hung, and S.N. Lu Correlation of quantitative assay of hepatitis B surface antigen and HBV DNA levels in asymptomatic hepatitis B virus carriers Eur J Gastroenterol Hepatol 16 2004 1213 1218
-
(2004)
Eur J Gastroenterol Hepatol
, vol.16
, pp. 1213-1218
-
-
Chen, C.H.1
Lee, C.M.2
Wang, J.H.3
Tung, H.D.4
Hung, C.H.5
Lu, S.N.6
-
13
-
-
2942532722
-
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy
-
B. Werle-Lapostolle, S. Bowden, S. Locarnini, K. Wursthorn, J. Petersen, and G. Lau et al. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy Gastroenterology 126 2004 1750 1758
-
(2004)
Gastroenterology
, vol.126
, pp. 1750-1758
-
-
Werle-Lapostolle, B.1
Bowden, S.2
Locarnini, S.3
Wursthorn, K.4
Petersen, J.5
Lau, G.6
-
14
-
-
77952716572
-
Serum hepatitis B surface antigen and hepatitis B e antigen titers: Disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers
-
A.J. Thompson, T. Nguyen, D. Iser, A. Ayres, K. Jackson, and M. Littlejohn et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers Hepatology 51 2010 1933 1944
-
(2010)
Hepatology
, vol.51
, pp. 1933-1944
-
-
Thompson, A.J.1
Nguyen, T.2
Iser, D.3
Ayres, A.4
Jackson, K.5
Littlejohn, M.6
-
15
-
-
77950594817
-
On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients
-
W. Cai, Q. Xie, B. An, H. Wang, X. Zhou, and G. Zhao et al. On-treatment serum HBsAg level is predictive of sustained off-treatment virologic response to telbivudine in HBeAg-positive chronic hepatitis B patients J Clin Virol 48 2010 22 26
-
(2010)
J Clin Virol
, vol.48
, pp. 22-26
-
-
Cai, W.1
Xie, Q.2
An, B.3
Wang, H.4
Zhou, X.5
Zhao, G.6
-
16
-
-
79960013101
-
Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy
-
Y. Liang, J. Jiang, M. Su, Z. Liu, W. Guo, and X. Huang et al. Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy Aliment Pharmacol Ther 34 2011 344 352
-
(2011)
Aliment Pharmacol Ther
, vol.34
, pp. 344-352
-
-
Liang, Y.1
Jiang, J.2
Su, M.3
Liu, Z.4
Guo, W.5
Huang, X.6
-
17
-
-
83455163799
-
Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen-negative patients
-
H.L. Chan, G.L. Wong, A.M. Chim, H.Y. Chan, S.H. Chu, and V.W. Wong Prediction of off-treatment response to lamivudine by serum hepatitis B surface antigen quantification in hepatitis B e antigen-negative patients Antivir Ther 16 2011 1249 1257
-
(2011)
Antivir Ther
, vol.16
, pp. 1249-1257
-
-
Chan, H.L.1
Wong, G.L.2
Chim, A.M.3
Chan, H.Y.4
Chu, S.H.5
Wong, V.W.6
-
18
-
-
84865376141
-
Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update
-
Y.F. Liaw, J.H. Kao, T. Piratvisuth, H.L.Y. Chan, R.N. Chien, and C.J. Liu et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update Hepatol Int 6 2012 531 561
-
(2012)
Hepatol Int
, vol.6
, pp. 531-561
-
-
Liaw, Y.F.1
Kao, J.H.2
Piratvisuth, T.3
Chan, H.L.Y.4
Chien, R.N.5
Liu, C.J.6
-
19
-
-
84865487986
-
Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir
-
S.J. Hadziyannis, V. Sevastianos, I. Rapti, D. Vassilopoulos, and E. Hadziyannis Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir Gastroenterology 143 2012 629 636
-
(2012)
Gastroenterology
, vol.143
, pp. 629-636
-
-
Hadziyannis, S.J.1
Sevastianos, V.2
Rapti, I.3
Vassilopoulos, D.4
Hadziyannis, E.5
-
20
-
-
0033045135
-
Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns
-
M. Mizokami, T. Nakano, E. Orito, Y. Tanaka, H. Sakugawa, and M. Mukaide et al. Hepatitis B virus genotype assignment using restriction fragment length polymorphism patterns FEBS Lett 450 1999 66 71
-
(1999)
FEBS Lett
, vol.450
, pp. 66-71
-
-
Mizokami, M.1
Nakano, T.2
Orito, E.3
Tanaka, Y.4
Sakugawa, H.5
Mukaide, M.6
-
21
-
-
0037260187
-
Prevalence and clinical implications of hepatitis B virus genotypes in southern Taiwan
-
C.M. Lee, C.H. Chen, S.N. Lu, H.D. Tung, W.J. Chou, and J.H. Wang et al. Prevalence and clinical implications of hepatitis B virus genotypes in southern Taiwan Scand J Gastroenterol 1 2003 95 101
-
(2003)
Scand J Gastroenterol
, vol.1
, pp. 95-101
-
-
Lee, C.M.1
Chen, C.H.2
Lu, S.N.3
Tung, H.D.4
Chou, W.J.5
Wang, J.H.6
-
22
-
-
0033797827
-
Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea
-
B.C. Song, D.J. Suh, H.C. Lee, Y.H. Chung, and Y.S. Lee Hepatitis B e antigen seroconversion after lamivudine therapy is not durable in patients with chronic hepatitis B in Korea Hepatology 32 2000 803 806
-
(2000)
Hepatology
, vol.32
, pp. 803-806
-
-
Song, B.C.1
Suh, D.J.2
Lee, H.C.3
Chung, Y.H.4
Lee, Y.S.5
-
23
-
-
0036844794
-
Durability of lamivudine induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation
-
C.M. Lee, G.Y. Ong, S.N. Lu, J.H. Wang, C.A. Liao, and H.D. Tung et al. Durability of lamivudine induced HBeAg seroconversion for chronic hepatitis B patients with acute exacerbation J Hepatol 37 2002 669 674
-
(2002)
J Hepatol
, vol.37
, pp. 669-674
-
-
Lee, C.M.1
Ong, G.Y.2
Lu, S.N.3
Wang, J.H.4
Liao, C.A.5
Tung, H.D.6
-
24
-
-
0142244873
-
Determinants for sustained HBeAg response to lamivudine therapy
-
R.N. Chien, C.T. Yeh, S.L. Tsai, C.M. Chu, and Y.F. Liaw Determinants for sustained HBeAg response to lamivudine therapy Hepatology 38 2003 1267 1273
-
(2003)
Hepatology
, vol.38
, pp. 1267-1273
-
-
Chien, R.N.1
Yeh, C.T.2
Tsai, S.L.3
Chu, C.M.4
Liaw, Y.F.5
-
25
-
-
84983726125
-
Young chronic hepatitis B patients with nucleos(t)ide analogue-induced hepatitis B e antigen seroconversion have a higher risk of HBV reactivation
-
T.C. Tseng, C.J. Liu, T.H. Su, H.C. Yang, C.C. Wang, and C.L. Chen et al. Young chronic hepatitis B patients with nucleos(t)ide analogue-induced hepatitis B e antigen seroconversion have a higher risk of HBV reactivation J Infect Dis 206 2012 1521 1531
-
(2012)
J Infect Dis
, vol.206
, pp. 1521-1531
-
-
Tseng, T.C.1
Liu, C.J.2
Su, T.H.3
Yang, H.C.4
Wang, C.C.5
Chen, C.L.6
-
26
-
-
68349128691
-
The duration of lamivudine therapy for chronic hepatitis B: Cessation vs. Continuation of treatment after HBeAg seroconversion
-
J. Fung, C.L. Lai, Y. Tanaka, M. Mizokami, J. Yuen, and D.K. Wong et al. The duration of lamivudine therapy for chronic hepatitis B: cessation vs. continuation of treatment after HBeAg seroconversion Am J Gastroenterol 104 2009 1940 1946
-
(2009)
Am J Gastroenterol
, vol.104
, pp. 1940-1946
-
-
Fung, J.1
Lai, C.L.2
Tanaka, Y.3
Mizokami, M.4
Yuen, J.5
Wong, D.K.6
-
27
-
-
75449093009
-
Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B
-
H.W. Lee, H.J. Lee, J.S. Hwang, J.H. Sohn, J.Y. Jang, and K.J. Han et al. Lamivudine maintenance beyond one year after HBeAg seroconversion is a major factor for sustained virologic response in HBeAg-positive chronic hepatitis B Hepatology 51 2010 415 421
-
(2010)
Hepatology
, vol.51
, pp. 415-421
-
-
Lee, H.W.1
Lee, H.J.2
Hwang, J.S.3
Sohn, J.H.4
Jang, J.Y.5
Han, K.J.6
-
28
-
-
34249090519
-
Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: A double-blind, placebo-controlled trial
-
H.L. Chan, H. Wang, J. Niu, A.M. Chim, and J.J. Sung Two-year lamivudine treatment for hepatitis B e antigen-negative chronic hepatitis B: a double-blind, placebo-controlled trial Antivir Ther 12 2007 345 353
-
(2007)
Antivir Ther
, vol.12
, pp. 345-353
-
-
Chan, H.L.1
Wang, H.2
Niu, J.3
Chim, A.M.4
Sung, J.J.5
-
29
-
-
79951623871
-
Poor durability of lamivudine effectiveness despite stringent cessation criteria: A prospective clinical study in hepatitis B e antigen negative chronic hepatitis B patients
-
F. Liu, L. Wang, X.Y. Li, Y.D. Liu, J.B. Wang, and Z.H. Zhang et al. Poor durability of lamivudine effectiveness despite stringent cessation criteria: a prospective clinical study in hepatitis B e antigen negative chronic hepatitis B patients J Gastroenterol Hepatol 26 2011 456 460
-
(2011)
J Gastroenterol Hepatol
, vol.26
, pp. 456-460
-
-
Liu, F.1
Wang, L.2
Li, X.Y.3
Liu, Y.D.4
Wang, J.B.5
Zhang, Z.H.6
-
30
-
-
0036789020
-
Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection
-
Y.C. Chen, I.S. Sheen, C.M. Chu, and Y.F. Liaw Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection Gastroenterology 123 2002 1084 1089
-
(2002)
Gastroenterology
, vol.123
, pp. 1084-1089
-
-
Chen, Y.C.1
Sheen, I.S.2
Chu, C.M.3
Liaw, Y.F.4
-
31
-
-
2542516261
-
HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects
-
M.F. Yuen, D.K. Wong, E. Sablon, E. Tse, I.O. Ng, and H.J. Yuan et al. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects Hepatology 39 2004 1694 1701
-
(2004)
Hepatology
, vol.39
, pp. 1694-1701
-
-
Yuen, M.F.1
Wong, D.K.2
Sablon, E.3
Tse, E.4
Ng, I.O.5
Yuan, H.J.6
-
32
-
-
84879843826
-
Combining HBsAg decline and HBV DNA levels predict clinical outcomes in patients with spontaneous HBeAg seroconversion
-
S.C. Yang, S.N. Lu, C.M. Lee, T.H. Hu, J.H. Wang, and C.H. Hung et al. Combining HBsAg decline and HBV DNA levels predict clinical outcomes in patients with spontaneous HBeAg seroconversion Hepatol Intern 7 2013 489 499
-
(2013)
Hepatol Intern
, vol.7
, pp. 489-499
-
-
Yang, S.C.1
Lu, S.N.2
Lee, C.M.3
Hu, T.H.4
Wang, J.H.5
Hung, C.H.6
-
33
-
-
84984552614
-
Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters
-
T.C. Tseng, C.J. Liu, T.H. Su, C.C. Wang, C.L. Chen, and P.J. Chen et al. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters Gastroenterology 141 2011 517 525
-
(2011)
Gastroenterology
, vol.141
, pp. 517-525
-
-
Tseng, T.C.1
Liu, C.J.2
Su, T.H.3
Wang, C.C.4
Chen, C.L.5
Chen, P.J.6
-
34
-
-
84984571825
-
Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load
-
T.C. Tseng, C.J. Liu, H.C. Yang, T.H. Su, C.C. Wang, and C.L. Chen et al. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load Hepatology 55 2012 68 76
-
(2012)
Hepatology
, vol.55
, pp. 68-76
-
-
Tseng, T.C.1
Liu, C.J.2
Yang, H.C.3
Su, T.H.4
Wang, C.C.5
Chen, C.L.6
-
35
-
-
84857194778
-
Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infection
-
Y.C. Chen, W.J. Jeng, C.M. Chu, and Y.F. Liaw Decreasing levels of HBsAg predict HBsAg seroclearance in patients with inactive chronic hepatitis B virus infection Clin Gastroenterol Hepatol 10 2012 297 302
-
(2012)
Clin Gastroenterol Hepatol
, vol.10
, pp. 297-302
-
-
Chen, Y.C.1
Jeng, W.J.2
Chu, C.M.3
Liaw, Y.F.4
-
36
-
-
84884319490
-
Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: Results from a nine-year longitudinal study
-
T. Hosaka, F. Suzuki, M. Kobayashi, Y. Seko, Y. Kawamura, and H. Sezaki et al. Clearance of hepatitis B surface antigen during long-term nucleot(s)ide analog treatment in chronic hepatitis B: results from a nine-year longitudinal study J Gastroenterol 48 2013 930 941
-
(2013)
J Gastroenterol
, vol.48
, pp. 930-941
-
-
Hosaka, T.1
Suzuki, F.2
Kobayashi, M.3
Seko, Y.4
Kawamura, Y.5
Sezaki, H.6
|